Worrall Douglas M, Lerner David K, Naunheim Matthew R, Woo Peak
1 Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Ann Otol Rhinol Laryngol. 2019 May;128(5):472-479. doi: 10.1177/0003489419826131. Epub 2019 Jan 24.
Describe the demographics and clinical manifestations of laryngeal cryptococcosis. Develop a simple approach to the diagnostic workup and treatment of localized laryngeal cryptococcal infection.
A new case of laryngeal cryptococcosis encountered at our institution is presented and placed in context of the literature surrounding prior reported cases. PubMed, Google Scholar, SCOPUS, and Web of Science were queried from inception to August 2018 with the terms Larynx or Laryngeal and Cryptococcosis or Cryptococcus by two independent reviewers for English-language cases of cryptococcal infection of the larynx.
Twenty-nine unique cases of laryngeal cryptococcosis were identified. Median age at presentation was 65 years old. All patients presented with persistent or progressive hoarseness. Lesions were predominantly on the true vocal cords (79%), 38% associated with an adherent white exudate or leukoplakia. A minority (28%) was immunocompromised, and of the remaining immunocompetent hosts, 67% were found to be using nebulized or inhaled corticosteroids (ICS) prior to infection. Diagnosis should be suspected in patients with chronic laryngitis or mass lesions with the aforementioned risk factors. Diagnosis was made by histopathology with cryptococcal yeasts identified on methenamine silver (55%) and/or mucicarmine stains (48%). Serum cryptococcal antigen testing was unreliable (sensitivity = 39%). The mainstay of effective treatment was prolonged oral Fluconazole therapy, with two cases of laser therapy ablation of residual lesions. Improvement in voice and vocal lesions varied from weeks to months.
Laryngeal cryptococcosis is a rare cause of persistent hoarseness, which appears to be clinically evolving and more frequently affecting immunocompetent hosts chronically using nebulized or inhaled corticosteroids. Laryngeal cryptococcal infection is readily treatable with prolonged oral antifungals once biopsy and histopathological stains confirm the diagnosis.
描述喉隐球菌病的人口统计学特征和临床表现。制定一种针对局限性喉隐球菌感染的诊断检查和治疗的简单方法。
介绍在我们机构遇到的一例新的喉隐球菌病病例,并结合先前报道病例的相关文献进行分析。两名独立审稿人从数据库创建至2018年8月,在PubMed、谷歌学术、SCOPUS和科学网中检索了英文的喉隐球菌感染病例,检索词为“喉”或“喉部”以及“隐球菌病”或“隐球菌”。
共识别出29例独特的喉隐球菌病病例。发病时的中位年龄为65岁。所有患者均表现为持续性或进行性声音嘶哑。病变主要位于真声带(79%),38%伴有附着的白色渗出物或白斑。少数患者(28%)存在免疫功能低下,在其余免疫功能正常的宿主中,67%在感染前使用过雾化或吸入性糖皮质激素(ICS)。对于有上述危险因素的慢性喉炎或肿块病变患者,应怀疑该病。通过组织病理学诊断,在亚甲胺银染色(55%)和/或黏液卡红染色(48%)中发现隐球菌酵母。血清隐球菌抗原检测不可靠(敏感性=39%)。有效治疗的主要方法是长期口服氟康唑治疗,有两例采用激光治疗消融残留病变。声音和声带病变的改善从数周至数月不等。
喉隐球菌病是持续性声音嘶哑的罕见原因,在临床上似乎在不断演变,并且更频繁地影响长期使用雾化或吸入性糖皮质激素的免疫功能正常宿主。一旦活检和组织病理学染色确诊,喉隐球菌感染通过长期口服抗真菌药物很容易治疗。